(Q34694948)

English

Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: randomized, double-blind, 5-year phase II study in healthy adults

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: randomized, double-blind, 5-year phase II study in healthy adults (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Japanese encephalitis virus

0 references

attenuated vaccine

1 reference

based on heuristic

inferred from title

Japanese encephalitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

object named as

John Aaskov

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

5

object named as

Sutee Yoksan

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Andrew Ebringer

2

object named as

Andrew Ebringer

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

Peter E Nasveld

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Nathan Elmes

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sonya Bennett

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Karen McCarthy

7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Niranjan Kanesa-thasan

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Claude Meric

9

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Mark Reid

10

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

1 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1038-1046

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060383

7 July 2018

WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1-2 June 2006.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060383

7 July 2018

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060383

7 July 2018

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060383

7 July 2018

Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060383

7 July 2018

Japanese encephalitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060383

7 July 2018

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-hu

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060383

7 July 2018

A plaque reduction test for dengue virus neutralizing antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060383

7 July 2018

Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060383

7 July 2018

Japanese encephalitis vaccine (inactivated, adsorbed) [IXIARO].

1 reference

https://api.crossref.org/works/10.4161%2FHV.6.12.13057

21 January 2018

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine

1 reference

https://api.crossref.org/works/10.4161%2FHV.6.12.13057

21 January 2018

A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/21150279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com

1 reference

https://pubmed.ncbi.nlm.nih.gov/21150279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004

1 reference

https://pubmed.ncbi.nlm.nih.gov/21150279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global Advisory Committee on Vaccine Safety, 9-10 June 2005

1 reference

https://pubmed.ncbi.nlm.nih.gov/21150279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4161/HV.6.12.13057

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34694948&oldid=1871199524"